ReP USP - Resultado da busca

Artigo de periodico
Understanding the elevated lethality of COVID-19 in liver transplant recipients: does immunosuppression management matter? results from a brazilian multicentric historical cohort (2023)
Boin, Ilka Fsf; Riccetto, Eduardo; Genzini, Tercio; Santos, Regina Gomes; Moreira, Lucio Figueira Pacheco; Pinto, Laura Cristina Machado; Garcia, Jose Huygens Parente; Stucchi, Raquel Sb; Perales, Simone Reges; D Albuquerque, Luiz Augusto Carneiro
Source: Transplantation proceedings. Unidade: FM
Subjects: ESTUDOS MULTICÊNTRICOS, COVID-19, IMUNOSSUPRESSÃO, TRANSPLANTE DE FÍGADO, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOIN, Ilka Fsf et al. Understanding the elevated lethality of COVID-19 in liver transplant recipients: does immunosuppression management matter? results from a brazilian multicentric historical cohort. Transplantation proceedings, v. 55, n. 8, p. 1815-1821, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57433. Acesso em: 05 nov. 2024.
APA
Boin, I. F., Riccetto, E., Genzini, T., Santos, R. G., Moreira, L. F. P., Pinto, L. C. M., et al. (2023). Understanding the elevated lethality of COVID-19 in liver transplant recipients: does immunosuppression management matter? results from a brazilian multicentric historical cohort. Transplantation proceedings, 55( 8), 1815-1821. doi:10.1016/j.transproceed.2023.05.007
NLM
Boin IF, Riccetto E, Genzini T, Santos RG, Moreira LFP, Pinto LCM, Garcia JHP, Stucchi RS, Perales SR, D Albuquerque LAC. Understanding the elevated lethality of COVID-19 in liver transplant recipients: does immunosuppression management matter? results from a brazilian multicentric historical cohort [Internet]. Transplantation proceedings. 2023 ; 55( 8): 1815-1821.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57433
Vancouver
Boin IF, Riccetto E, Genzini T, Santos RG, Moreira LFP, Pinto LCM, Garcia JHP, Stucchi RS, Perales SR, D Albuquerque LAC. Understanding the elevated lethality of COVID-19 in liver transplant recipients: does immunosuppression management matter? results from a brazilian multicentric historical cohort [Internet]. Transplantation proceedings. 2023 ; 55( 8): 1815-1821.[citado 2024 nov. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57433
Artigo de periodico
COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil (2022)
Samaan, Farid; Paula, Elisa Carneiro de; Souza, Fabrizzio Batista Guimaraes de Lima; Mendes, Luiz Fernando Cardoso; Rossi, Paula Regina Gan; Freitas, Rafaela Andrade Penalva; Nakagawa, Fernando Takahashi; Maciel, Alexandre Toledo; Aranha, Sylvia; Burdmann, Emmanuel de Almeida
Source: Plos one. Unidade: FM
Subjects: COVID-19, ESTUDOS MULTICÊNTRICOS, INSUFICIÊNCIA RENAL AGUDA, PACIENTES INTERNADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMAAN, Farid et al. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil. Plos one, v. 17, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0261958. Acesso em: 05 nov. 2024.
APA
Samaan, F., Paula, E. C. de, Souza, F. B. G. de L., Mendes, L. F. C., Rossi, P. R. G., Freitas, R. A. P., et al. (2022). COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil. Plos one, 17( 1). doi:10.1371/journal.pone.0261958
NLM
Samaan F, Paula EC de, Souza FBG de L, Mendes LFC, Rossi PRG, Freitas RAP, Nakagawa FT, Maciel AT, Aranha S, Burdmann E de A. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil [Internet]. Plos one. 2022 ; 17( 1):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1371/journal.pone.0261958
Vancouver
Samaan F, Paula EC de, Souza FBG de L, Mendes LFC, Rossi PRG, Freitas RAP, Nakagawa FT, Maciel AT, Aranha S, Burdmann E de A. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: a multicenter study in SAo Paulo, Brazil [Internet]. Plos one. 2022 ; 17( 1):[citado 2024 nov. 05 ] Available from: https://doi.org/10.1371/journal.pone.0261958
Trabalho de evento-resumo periodico
Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) (2021)
Bonifacio, L.; Ramacciotti, E.; Agati, L.; Vilar, F.; Tojal, A.; Souza, H.; Louzada Júnior, Paulo; Fonseca, Benedito Antonio Lopes da; Lopes, R.; Kallas, Esper Georges ; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, CITOCINAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 05 nov. 2024. , 2021
APA
Bonifacio, L., Ramacciotti, E., Agati, L., Vilar, F., Tojal, A., Souza, H., et al. (2021). Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects